Literature DB >> 16153792

Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.

M R Abbaspour1, F Sadeghi, H Afrasiabi Garekani.   

Abstract

The aim of this study was to assess the application of Eudragit RL PO and RS PO and their combination for production of ibuprofen pellets by extrusion-spheronization. The pellets were prepared based on full factorial design. Independent variables were % ibuprofen (40, 60, 80), the ratio of Eudragit RS to Eudragit RL (1:0, 1:1, 0:1) and % PVP (1, 3, 5). The evaluated responses were mean dissolution time (MDT), crushing strength and elastic modulus of pellets. Surface characteristics, sphericity and aspect ratio of pellets were also evaluated. Linear regression and response surface modeling was used for analyzing results. It was shown that the amount of water required to prepare a proper wet mass was affected by composition of formulations. The required amount of water decreased with increasing drug load and percent of PVP. It was also shown that formulations containing Eudragit RL need more water. Increasing percent of PVP slightly decreased MDT and elastic modulus but had negligible effect on crushing strength. Increasing the percent of ibuprofen up to 60% decreased MDT but beyond that increased MDT. Increasing the percent of ibuprofen also decreased elastic modulus of pellets. Eudragit RL PO compare with Eudragit RS PO resulted in pellets with high crushing strength; however, Eudragit type did not have a significant effect on elastic modulus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153792     DOI: 10.1016/j.ijpharm.2005.07.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pellets.

Authors:  Abdullah S Alshetaili; Bjad K Almutairy; Saad M Alshahrani; Eman A Ashour; Roshan V Tiwari; Sultan M Alshehri; Xin Feng; Bader B Alsulays; Soumyajit Majumdar; Nigel Langley; Karl Kolter; Andreas Gryczke; Scott T Martin; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2016-05-04       Impact factor: 3.225

2.  Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.

Authors:  Yeo-Song Lee; Jae Guen Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization.

Authors:  Hadi Afrasiabi Garekani; Roshanak Dolatabadi; Abbas Akhgari; Mohammad Reza Abbaspour; Fatemeh Sadeghi
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

4.  Production of Ibuprofen Pellets Containing High Amount of Rate Retarding Eudragit RL Using PEG400 and Investigation of Their Physicomechanical Properties.

Authors:  Fatemeh Sadeghi; Hasan Hijazi; Hadi Afrasiabi Garekani
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

5.  QbD based Eudragit coated Meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-Fluorescence detection method.

Authors:  Faaiza Qazi; Muhammad Harris Shoaib; Rabia Ismail Yousuf; Fahad Siddiqui; Muhammad Iqbal Nasiri; Kamran Ahmed; Iyad Naeem Muhammad; Farrukh Rafiq Ahmed
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.